ONDANSETRON HCL 4 MG/2 ML VIAL
Ondansetron HCL 4 MG/2 ML vial, a generic anti-nausea medication, has an acquisition cost of $0.20 while hospitals typically charge patients significantly more for the same dose.
About the analyst
Kevin Nyk analyzes hospital pricing data at BillRazor Research. He specializes in Medicare reimbursement patterns and chargemaster pricing across U.S. hospitals. Expertise: hospital pricing, Medicare rates, chargemaster analysis.
Ondansetron HCL is an anti-nausea medication commonly administered in hospital settings for chemotherapy patients and post-operative care. This injectable formulation typically generates higher facility charges compared to oral tablets, with potential billing variations of several hundred dollars between inpatient and outpatient administration codes.
No credit card required. Results in 60 seconds.
Common billing errors — GI / Acid Suppression charges
Hospital billing for GI and acid suppression medications frequently shows charges above the benchmark, with markups ranging from 300-800% over the average $0.25 NADAC acquisition cost. Common billing issues include duplicate charges when patients receive both immediate-release and extended-release formulations of the same medication, such as omeprazole, without clear documentation of medical necessity. Generic substitution problems occur when hospitals bill for brand-name proton pump inhibitors like Nexium while dispensing generic esomeprazole, creating potential differences of $15-40 per dose. Patients should verify that IV formulations are appropriately billed only when oral administration is contraindicated, as IV pantoprazole can be charged at 10-15 times the cost of oral equivalents. Bundle billing errors also appear when acid suppressants administered as part of surgical protocols are separately itemized rather than included in procedure costs, particularly with histamine-2 receptor antagonists like famotidine.
FAQ — GI / Acid Suppression billing
What is the average acquisition cost for GI/Acid Suppression drugs?
How many drugs are included in the GI/Acid Suppression class for billing purposes?
How should charges above the benchmark be documented for GI/Acid Suppression drugs?
What billing considerations apply when reviewing GI/Acid Suppression drug costs?
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.